Vigabatrin Tablet
Product Images NDC 42799-950

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 42799-950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Edenbridge Pharmaceuticals Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line chart depicting the percentage reduction in seizure frequency versus the percentage of patients. The graph compares placebo and three doses (1 g/day, 3 g/day, and 6 g/day) of Vigabatrin (VGB). The y-axis shows improvement or worsening in seizure frequency, with a reference line at no change. The x-axis shows the percentage of patients responding.*
FDA Label Image

2 (Figure2)

2 (Figure2)
A line graph comparing the percentage reduction in seizure frequency among patients. The x-axis represents the percentage of patients, while the y-axis shows the percentage reduction in seizure frequency, ranging from worsening to improvement. Two curves are shown, labeled as Placebo and 3g/day Vigabatrin (VGB), illustrating patient response distribution.*
FDA Label Image

100 (Vigabatrin Label)

100 (Vigabatrin Label)
Vigabatrin Tablets USP 500 mg tablet label from Edenbridge Pharmaceuticals LLC. The label states the product contains 100 tablets, Rx only, with storage instructions at 20° to 25°C. Manufactured by Dexcel Pharma Technologies Ltd. in Israel and distributed by Edenbridge Pharmaceuticals LLC in Parsippany, NJ. Includes a barcode and a notice to dispense the accompanying medication guide.*
FDA Label Image

Structure (Vigabatrin Structure)

Structure (Vigabatrin Structure)
Chemical structure of Vigabatrin, showing the molecular arrangement including an amino group, carboxyl group, and vinyl group characteristic of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.